Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Clinical Trial to Evaluate Pharmacokinetics and Safety of Slow Release DHEA

NCT05623059 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT05623059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05623059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Clinical Trial to Evaluate Pharmacokinetics and Safety of Slow Release DHEA
Lead sponsor
Indiana University
Phase
Phase 1/2
Overall status
Completed
Start date
March 3, 2023
Completion date
April 24, 2025
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, genotype